SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-306712
Filing Date
2021-10-25
Accepted
2021-10-25 17:09:31
Documents
4
Period of Report
2021-10-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d135977d8k.htm 8-K 20774
2 EX-3.1 d135977dex31.htm EX-3.1 27684
3 EX-3.2 d135977dex32.htm EX-3.2 162066
4 EX-99.1 d135977dex991.htm EX-99.1 5525
  Complete submission text file 0001193125-21-306712.txt   217234
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 211344960
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences